These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 24602347

  • 1. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: review of evidence and need for knowledge.
    Cardoso O, Porcher JM, Sanchez W.
    Chemosphere; 2014 Nov; 115():20-30. PubMed ID: 24602347
    [Abstract] [Full Text] [Related]

  • 2. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
    Carlsson C, Johansson AK, Alvan G, Bergman K, Kühler T.
    Sci Total Environ; 2006 Jul 01; 364(1-3):67-87. PubMed ID: 16257037
    [Abstract] [Full Text] [Related]

  • 3. Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms.
    Mezzelani M, Gorbi S, Regoli F.
    Mar Environ Res; 2018 Sep 01; 140():41-60. PubMed ID: 29859717
    [Abstract] [Full Text] [Related]

  • 4. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.
    Zenker A, Cicero MR, Prestinaci F, Bottoni P, Carere M.
    J Environ Manage; 2014 Jan 15; 133():378-87. PubMed ID: 24419205
    [Abstract] [Full Text] [Related]

  • 5. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients.
    Carlsson C, Johansson AK, Alvan G, Bergman K, Kühler T.
    Sci Total Environ; 2006 Jul 01; 364(1-3):88-95. PubMed ID: 16260028
    [Abstract] [Full Text] [Related]

  • 6. Pollution pathways of pharmaceutical residues in the aquatic environment on the island of Mallorca, Spain.
    Rodríguez-Navas C, Björklund E, Bak SA, Hansen M, Krogh KA, Maya F, Forteza R, Cerdà V.
    Arch Environ Contam Toxicol; 2013 Jul 01; 65(1):56-66. PubMed ID: 23440447
    [Abstract] [Full Text] [Related]

  • 7. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
    Cunningham VL, Binks SP, Olson MJ.
    Regul Toxicol Pharmacol; 2009 Feb 01; 53(1):39-45. PubMed ID: 19013494
    [Abstract] [Full Text] [Related]

  • 8. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.
    Huerta B, Rodríguez-Mozaz S, Barceló D.
    Anal Bioanal Chem; 2012 Nov 01; 404(9):2611-24. PubMed ID: 22678760
    [Abstract] [Full Text] [Related]

  • 9. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment.
    Zuccato E, Castiglioni S, Fanelli R.
    J Hazard Mater; 2005 Jul 15; 122(3):205-9. PubMed ID: 15967275
    [Abstract] [Full Text] [Related]

  • 10. Managing emissions of active pharmaceutical ingredients from manufacturing facilities: an environmental quality standard approach.
    Murray-Smith RJ, Coombe VT, Grönlund MH, Waern F, Baird JA.
    Integr Environ Assess Manag; 2012 Apr 15; 8(2):320-30. PubMed ID: 22057894
    [Abstract] [Full Text] [Related]

  • 11. Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection.
    Roos V, Gunnarsson L, Fick J, Larsson DG, Rudén C.
    Sci Total Environ; 2012 Apr 01; 421-422():102-10. PubMed ID: 22361586
    [Abstract] [Full Text] [Related]

  • 12. Effects of human pharmaceuticals on aquatic life: next steps.
    Cunningham VL, Buzby M, Hutchinson T, Mastrocco F, Parke N, Roden N.
    Environ Sci Technol; 2006 Jun 01; 40(11):3456-62. PubMed ID: 16786680
    [No Abstract] [Full Text] [Related]

  • 13. An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research.
    Caldwell DJ, Mastrocco F, Margiotta-Casaluci L, Brooks BW.
    Chemosphere; 2014 Nov 01; 115():4-12. PubMed ID: 24636702
    [Abstract] [Full Text] [Related]

  • 14. Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals.
    Boxall AB, Keller VD, Straub JO, Monteiro SC, Fussell R, Williams RJ.
    Environ Int; 2014 Dec 01; 73():176-85. PubMed ID: 25127044
    [Abstract] [Full Text] [Related]

  • 15. Systematic screening of common wastewater-marking pharmaceuticals in urban aquatic environments: implications for environmental risk control.
    Zhou H, Zhang Q, Wang X, Zhang Q, Ma L, Zhan Y.
    Environ Sci Pollut Res Int; 2014 Dec 01; 21(11):7113-29. PubMed ID: 24557805
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Occurrence patterns of pharmaceuticals in water and wastewater environments.
    Nikolaou A, Meric S, Fatta D.
    Anal Bioanal Chem; 2007 Feb 01; 387(4):1225-34. PubMed ID: 17205270
    [Abstract] [Full Text] [Related]

  • 18. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment.
    Santos LH, Araújo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MC.
    J Hazard Mater; 2010 Mar 15; 175(1-3):45-95. PubMed ID: 19954887
    [Abstract] [Full Text] [Related]

  • 19. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
    Christensen AM, Markussen B, Baun A, Halling-Sørensen B.
    Chemosphere; 2009 Oct 15; 77(3):351-8. PubMed ID: 19682723
    [Abstract] [Full Text] [Related]

  • 20. Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China.
    Liu JL, Wong MH.
    Environ Int; 2013 Sep 15; 59():208-24. PubMed ID: 23838081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.